LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study-Reference-Cited by-同舟云学术

LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study

Published:2010-01-21 Issue:4 Volume:62 Page:929-939
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis & Rheumatism

Author:

Genovese M. C.,Van den Bosch F.,Roberson S. A.,Bojin S.,Biagini I. M.,Ryan Peter,Sloan-Lancaster J.

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.27334/fullpdf

Reference26 articles.

1. Unmet needs in rheumatoid arthritis;Moreland;Arthritis Res Ther,2005

2. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis;Felson;Arthritis Rheum,1995

3. Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis;Prevoo;Arthritis Rheum,1995

Cited by 400 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research progress of SREBP and its role in the pathogenesis of autoimmune rheumatic diseases;Frontiers in Immunology;2024-08-19

2. Causal associations between both psoriasis and psoriatic arthritis and multiple autoimmune diseases: a bidirectional two-sample Mendelian randomization study;Frontiers in Immunology;2024-07-25

3. From bench to bedside - is there a role of IL-17 drugs in rheumatoid arthritis?;Expert Opinion on Investigational Drugs;2024-05-09

4. Involvement of IL-17 A/IL-17 Receptor A with Neutrophil Recruitment and the Severity of Coronary Arteritis in Kawasaki Disease;Journal of Clinical Immunology;2024-03-07

5. Low doses of fluoxetine for the treatment of emotional premenstrual syndrome: a randomized double-blind, placebo-controlled, pilot study;Psychoneuroendocrinology;2023-11